Sanofi (LON:0O59)

Accolade Statistics

Total Valuation

Sanofi has a market cap or net worth of GBP 85.40 billion. The enterprise value is 91.67 billion.

Market Cap	85.40B
Enterprise Value	91.67B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	May 12, 2025

Share Statistics

Current Share Class	1.22B
Shares Outstanding	n/a
Shares Change (YoY)	-0.95%
Shares Change (QoQ)	-1.36%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.10B

Valuation Ratios

The trailing PE ratio is 10.92 and the forward PE ratio is 9.84.

PE Ratio	10.92
Forward PE	9.84
PS Ratio	2.18
PB Ratio	1.42
P/TBV Ratio	5.74
P/FCF Ratio	10.47
P/OCF Ratio	8.88
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.37, with an EV/FCF ratio of 11.24.

EV / Earnings	11.72
EV / Sales	2.30
EV / EBITDA	8.37
EV / EBIT	11.01
EV / FCF	11.24

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.32.

Current Ratio	1.27
Quick Ratio	0.81
Debt / Equity	0.32
Debt / EBITDA	1.80
Debt / FCF	2.34
Interest Coverage	16.85

Financial Efficiency

Return on equity (ROE) is 9.00% and return on invested capital (ROIC) is 6.20%.

Return on Equity (ROE)	9.00%
Return on Assets (ROA)	4.60%
Return on Invested Capital (ROIC)	6.20%
Return on Capital Employed (ROCE)	9.78%
Revenue Per Employee	473,060
Profits Per Employee	94,389
Employee Count	82,878
Asset Turnover	0.36
Inventory Turnover	1.30

Taxes

In the past 12 months, Sanofi has paid 1.32 billion in taxes.

Income Tax	1.32B
Effective Tax Rate	19.24%

Stock Price Statistics

The stock price has decreased by -16.04% in the last 52 weeks. The beta is 0.40, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-16.04%
50-Day Moving Average	84.95
200-Day Moving Average	94.27
Relative Strength Index (RSI)	37.91
Average Volume (20 Days)	479,193

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of GBP 39.21 billion and earned 7.82 billion in profits. Earnings per share was 6.31.

Revenue	39.21B
Gross Profit	27.96B
Operating Income	8.04B
Pretax Income	6.84B
Net Income	7.82B
EBITDA	10.36B
EBIT	8.04B
Earnings Per Share (EPS)	6.31

Balance Sheet

The company has 13.17 billion in cash and 19.10 billion in debt, giving a net cash position of -5.94 billion.

Cash & Cash Equivalents	13.17B
Total Debt	19.10B
Net Cash	-5.94B
Net Cash Per Share	n/a
Equity (Book Value)	60.24B
Book Value Per Share	49.31
Working Capital	6.82B

Cash Flow

In the last 12 months, operating cash flow was 9.61 billion and capital expenditures -1.45 billion, giving a free cash flow of 8.16 billion.

Operating Cash Flow	9.61B
Capital Expenditures	-1.45B
Free Cash Flow	8.16B
FCF Per Share	n/a

Margins

Gross margin is 71.32%, with operating and profit margins of 20.51% and 19.95%.

Gross Margin	71.32%
Operating Margin	20.51%
Pretax Margin	17.46%
Profit Margin	19.95%
EBITDA Margin	26.42%
EBIT Margin	20.51%
FCF Margin	20.81%

Dividends & Yields

This stock pays an annual dividend of 3.30, which amounts to a dividend yield of 4.12%.

Dividend Per Share	3.30
Dividend Yield	4.12%
Dividend Growth (YoY)	2.06%
Years of Dividend Growth	1
Payout Ratio	52.29%
Buyback Yield	0.95%
Shareholder Yield	5.07%
Earnings Yield	9.16%
FCF Yield	9.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6